TWENTY-FIRST CENTURY GROUP, INC.

Lobbying for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) · Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate · $24,000.00 income · posted Apr 21, 2025

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Veterans

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Health Issues

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.